ENTHALPY AND ENTROPY CONTRIBUTIONS TO THE SOLUBILITY OF SULPHAMETHOXYPYRIDAZINE IN SOLVENT MIXTURES SHOWING 2 SOLUBILITY MAXIMA

被引:48
作者
BUSTAMANTE, P
ESCALERA, B
机构
[1] Department of Farmacia y Tecnologia Farmaceutica, Facultad de Farmacia, Universidad de Alcala de Henares, Madrid
关键词
D O I
10.1111/j.2042-7158.1995.tb06712.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The solubility of sulphamethoxypyridazine was measured at several temperatures in mixtures of water:ethanol and ethanol:ethyl acetate. Sulphamethoxypyridazine was chosen as a model drug to compare the solvation effects of proton donor-proton acceptor (water and ethanol) and proton acceptor (ethyl acetate) solvents and mixtures of these solvents because this drug contains functional groups capable of Lewis acid-base interaction. A plot of the mole fraction solubility against the solubility parameter (delta(1)) of these solvent mixtures showed two solubility maxima, one at delta(1) = 30.87 MPa(1/2) (20:80 v/v water:ethanol) and another at delta(1) = 20.88 MPa(1/2) (30:70 v/v ethanol:ethyl acetate) at all the temperatures under study, The enthalpies and entropies of mixing as well as the enthalpies and entropies of transfer of sulphamethoxypyridazine from ethanol to water:ethanol and ethanol:ethyl acetate mixtures were calculated to compare solvation characteristics of the solvent mixtures toward the drug. As ethanol is added to water, the entropy increases and the structure of the solvent mixture became less ordered, favouring the interaction of the drug with the solvent mixture. On the other hand, in the case of the ethanol:ethyl acetate mixture, solubility is favoured by the more negative enthalpy values. This way, the same result, i.e, a solubility maximum, is obtained by different routes. In the ethanol:water mixtures, the dissolution process is entropy-controlled while enthalpy is the driving force in the case of ethanol:ethyl acetate mixtures. The two solvent systems show enthalpy-entropy compensation. Water deviates from the linear relationship due possibly to its hydrophobic effect.
引用
收藏
页码:550 / 555
页数:6
相关论文
共 26 条
[1]   SULFA DRUGS - THERMODYNAMIC PROTON LIGAND AND METAL-LIGAND STABILITY-CONSTANTS [J].
AGRAWAL, YK ;
GIRIDHAR, R ;
MENON, SK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (12) :903-906
[2]   STUDIES OF HYDROGEN-BONDED COMPLEX FORMATION .3. THERMODYNAMICS OF COMPLEXING BY INFRARED SPECTROSCOPY AND CALORIMETRY [J].
ARNETT, EM ;
JORIS, L ;
MITCHELL, E ;
MURTY, TSSR ;
GORRIE, TM ;
SCHLEYER, PV .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1970, 92 (08) :2365-+
[3]  
BUSTAMANTE P, 1994, CHEM PHARM BULL, V42, P1129
[4]   THE SOLUBILITY OF BENZOIC ACID IN MIXED SOLVENTS [J].
CHERTKOFF, MJ ;
MARTIN, AN .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1960, 49 (07) :444-447
[5]   PREDICTING THE SOLUBILITY OF DRUGS IN SOLVENT MIXTURES - MULTIPLE SOLUBILITY MAXIMA AND THE CHAMELEONIC EFFECT [J].
ESCALERA, JB ;
BUSTAMANTE, P ;
MARTIN, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (03) :172-176
[6]   CYCLOPHANE ARENE INCLUSION COMPLEXATION IN PROTIC SOLVENTS - SOLVENT EFFECTS VERSUS ELECTRON-DONOR ACCEPTOR INTERACTIONS [J].
FERGUSON, SB ;
SANFORD, EM ;
SEWARD, EM ;
DIEDERICH, F .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (14) :5410-5419
[7]   DISSOLUTION AND PARTITION THERMODYNAMIC FUNCTIONS OF SOME NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
FINI, A ;
LAUS, M ;
ORIENTI, I ;
ZECCHI, V .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (01) :23-25
[8]  
FOWKES FM, 1984, ACS M PHILADELPHIA, P522
[9]  
Grant D. J. W., 1990, TECHNIQUES CHEM, VXXI
[10]   FLUORIDE SOLVATION - THE CASE OF THE MISSING ION [J].
HEFTER, GT .
PURE AND APPLIED CHEMISTRY, 1991, 63 (12) :1749-1758